Medication Brand Names Beginning with ‘I’, Page 35

Page 35 of 135 « First Page « … 5 10 15 20 25 … 33 34 35 36 37 … 40 45 50 55 60 … » Last Page »

Imatinib Mesylate

Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+…

Sun Pharmaceutical Industries, Inc.7 September 2022

Imatinib Mesylate

Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia…

Hikma Pharmaceuticals USA Inc.31 August 2022

Imatinib Mesylate

Imatinib mesylate tablets are a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid…

Teva Pharmaceuticals USA, Inc.30 August 2022

Imatinib Mesylate

NDC 70771-1394-9. Imatinib Mesylate Tablets, 100 mg. 90 Tablets Rx only. NDC 70771-1395-9. Imatinib Mesylate Tablets, 400 mg. 90 Tablets Rx only. 100 mg 400 mg.

Zydus Lifesciences Limited13 October 2022

Imatinib Mesylate

Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia…

BluePoint Laboratories30 September 2022

Page 35 of 135 « First Page « … 5 10 15 20 25 … 33 34 35 36 37 … 40 45 50 55 60 … » Last Page »

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.